|
SNX14 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.002900E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.801400E-04 |
| Normal-vs-Stage2 |
2.743800E-02 |
| Normal-vs-Stage3 |
2.211500E-02 |
| Normal-vs-Stage4 |
1.639590E-02 |
| Stage1-vs-Stage2 |
9.818800E-01 |
| Stage1-vs-Stage3 |
7.021600E-01 |
| Stage1-vs-Stage4 |
7.371000E-01 |
| Stage2-vs-Stage3 |
7.772400E-01 |
| Stage2-vs-Stage4 |
7.396000E-01 |
| Stage3-vs-Stage4 |
9.491000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.968100E-04 |
| Normal-vs-AfricanAmerican |
3.352200E-02 |
| Normal-vs-Asian |
2.840500E-02 |
| Caucasian-vs-AfricanAmerican |
4.845800E-01 |
| Caucasian-vs-Asian |
6.857400E-01 |
| AfricanAmerican-vs-Asian |
4.849600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.371240E-04 |
| Normal-vs-Female |
1.956220E-01 |
| Male-vs-Female |
2.134400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.559360E-03 |
| Normal-vs-Extreme_Weight |
4.00150000001709E-06 |
| Normal-vs-Obese |
2.440100E-02 |
| Normal-vs-Extreme_Obese |
3.172400E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.992800E-01 |
| Normal_Weight-vs-Obese |
2.686000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.705800E-01 |
| Extreme_Weight-vs-Obese |
3.799700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.082200E-01 |
| Obese-vs-Extreme_Obese |
9.592400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.429600E-02 |
| Normal-vs-Age(41-60Yrs) |
4.078400E-02 |
| Normal-vs-Age(61-80Yrs) |
2.791700E-04 |
| Normal-vs-Age(81-100Yrs) |
3.590800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.724000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.613800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.238200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.882400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.144100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.501000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.213720E-02 |
| Normal-VS-Type2 PRCC |
1.915290E-03 |
| Normal-VS-KIRP CIMP |
3.971800E-02 |
| Normal-VS-Unclassified PRCC |
1.260310E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.381240E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.277800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.461800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.868200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.714000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.704600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.09469999999934E-05 |
| Normal-vs-N1 |
1.663430E-01 |
| Normal-vs-N2 |
7.64570000000298E-05 |
| N0-vs-N1 |
7.386400E-02 |
| N0-vs-N2 |
1.584360E-01 |
| N1-vs-N2 |
4.601900E-02 |
|
|
